95 related articles for article (PubMed ID: 29776718)
1. High urinary ferritin reflects myoglobin iron evacuation in DMD patients.
Rouillon J; Lefebvre T; Denard J; Puy V; Daher R; Ausseil J; Zocevic A; Fogel P; Peoc'h K; Wong B; Servais L; Voit T; Puy H; Karim Z; Svinartchouk F
Neuromuscul Disord; 2018 Jul; 28(7):564-571. PubMed ID: 29776718
[TBL] [Abstract][Full Text] [Related]
2. Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy.
Rouillon J; Zocevic A; Leger T; Garcia C; Camadro JM; Udd B; Wong B; Servais L; Voit T; Svinartchouk F
Neuromuscul Disord; 2014 Jul; 24(7):563-73. PubMed ID: 24813925
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients.
Awano H; Matsumoto M; Nagai M; Shirakawa T; Maruyama N; Iijima K; Nabeshima YI; Matsuo M
Clin Chim Acta; 2018 Jan; 476():111-116. PubMed ID: 29175173
[TBL] [Abstract][Full Text] [Related]
4. A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years old.
Nakagawa T; Takeuchi A; Kakiuchi R; Lee T; Yagi M; Awano H; Iijima K; Takeshima Y; Urade Y; Matsuo M
Clin Chim Acta; 2013 Aug; 423():10-4. PubMed ID: 23603101
[TBL] [Abstract][Full Text] [Related]
5. Urinary prostaglandin metabolites as Duchenne muscular dystrophy progression markers.
Takeshita E; Komaki H; Tachimori H; Miyoshi K; Yamamiya I; Shimizu-Motohashi Y; Ishiyama A; Saito T; Nakagawa E; Sugai K; Sasaki M
Brain Dev; 2018 Nov; 40(10):918-925. PubMed ID: 30006121
[TBL] [Abstract][Full Text] [Related]
6. Receiver operating curve analyses of urinary titin of healthy 3-y-old children may be a noninvasive screening method for Duchenne muscular dystrophy.
Matsuo M; Shirakawa T; Awano H; Nishio H
Clin Chim Acta; 2018 Nov; 486():110-114. PubMed ID: 30053403
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients.
Catapano F; Domingos J; Perry M; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Niks EH; Verschuuren JJ; Straub V; Voit T; Morgan J; Muntoni F
Epigenomics; 2018 Jul; 10(7):875-889. PubMed ID: 29564913
[TBL] [Abstract][Full Text] [Related]
8. Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy.
Beekman C; Janson AA; Baghat A; van Deutekom JC; Datson NA
PLoS One; 2018; 13(4):e0195850. PubMed ID: 29641567
[TBL] [Abstract][Full Text] [Related]
9. Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy.
Hathout Y; Brody E; Clemens PR; Cripe L; DeLisle RK; Furlong P; Gordish-Dressman H; Hache L; Henricson E; Hoffman EP; Kobayashi YM; Lorts A; Mah JK; McDonald C; Mehler B; Nelson S; Nikrad M; Singer B; Steele F; Sterling D; Sweeney HL; Williams S; Gold L
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7153-8. PubMed ID: 26039989
[TBL] [Abstract][Full Text] [Related]
10. Renal function in children and adolescents with Duchenne muscular dystrophy.
Braat E; Hoste L; De Waele L; Gheysens O; Vermeersch P; Goffin K; Pottel H; Goemans N; Levtchenko E
Neuromuscul Disord; 2015 May; 25(5):381-7. PubMed ID: 25683700
[TBL] [Abstract][Full Text] [Related]
11. The L-arginine/NO pathway and homoarginine are altered in Duchenne muscular dystrophy and improved by glucocorticoids.
Hörster I; Weigt-Usinger K; Carmann C; Chobanyan-Jürgens K; Köhler C; Schara U; Kayacelebi AA; Beckmann B; Tsikas D; Lücke T
Amino Acids; 2015 Sep; 47(9):1853-63. PubMed ID: 26066683
[TBL] [Abstract][Full Text] [Related]
12. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
13. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup.
Matsumoto M; Awano H; Lee T; Takeshima Y; Matsuo M; Iijima K
Neuromuscul Disord; 2017 Nov; 27(11):1023-1028. PubMed ID: 28734761
[TBL] [Abstract][Full Text] [Related]
14. [Central nervous system involvements in Duchenne/Becker muscular dystrophy].
Kumagai T; Miura K; Ohki T; Matsumoto A; Miyazaki S; Nakamura M; Ochi N; Takahashi O
No To Hattatsu; 2001 Nov; 33(6):480-6. PubMed ID: 11725514
[TBL] [Abstract][Full Text] [Related]
15. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies.
Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H
Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784
[TBL] [Abstract][Full Text] [Related]
16. Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.
Wilson K; Faelan C; Patterson-Kane JC; Rudmann DG; Moore SA; Frank D; Charleston J; Tinsley J; Young GD; Milici AJ
Toxicol Pathol; 2017 Oct; 45(7):961-976. PubMed ID: 28974147
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis of cognitive disorders in patients with Duchenne muscular dystrophy].
Sokolova MG; Lobzin SV; Nikishina OA; Kiselev AV; Rezvantsev MV; Litvinenko IV; Gavrichenko AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):78-84. PubMed ID: 29376988
[TBL] [Abstract][Full Text] [Related]
18. [Cardiologic study of 10 patients with Duchenne muscular dystrophy(DMD): personal experience].
Falsaperla R; Romeo G; Sciacca P; Di Giorgio A; Mattia CL; Distefano G
Pediatr Med Chir; 2001; 23(1):57-60. PubMed ID: 11486424
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.
Elhawary NA; Jiffri EH; Jambi S; Mufti AH; Dannoun A; Kordi H; Khogeer A; Jiffri OH; Elhawary AN; Tayeb MT
Hum Genomics; 2018 Apr; 12(1):18. PubMed ID: 29631625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
